MODIFIED ASTHMA AND COPD
MEDICATIONS OVERVIEW: 2025/2026,
WITH CORRECT/ACCURATE ANSWERS
QUICK REFERENCE
KEY ADVERSE EFFECTS
Ipratropium: Dry mouth, irritation of the pharynx, increased
intraocular pressure in glaucoma patients.
Albuterol: Tachycardia, angina, tremors, especially with oral
preparations.
Montelukast: Neuropsychiatric effects including depression
and suicidal thoughts.
Beclomethasone: Oropharyngeal candidiasis, dysphonia,
adrenal suppression with long-term use.
Roflumilast: Diarrhea, weight loss, nausea, and potential
reproductive issues.
KEY MONITORING PARAMETERS
Peak Expiratory Flow (PEF): Regular monitoring to assess
asthma control and medication effectiveness.
Liver Function Tests (LFTs): Important for monitoring
patients on isoniazid and other hepatotoxic medications.
Symptom Intensity and Frequency: Monitoring for changes in
asthma symptoms, nighttime awakenings, and short-acting
beta agonist use.
Therapeutic Drug Monitoring: Essential for drugs with narrow
therapeutic ranges like theophylline.
MEDICATIONS OVERVIEW: 2025/2026,
WITH CORRECT/ACCURATE ANSWERS
QUICK REFERENCE
KEY ADVERSE EFFECTS
Ipratropium: Dry mouth, irritation of the pharynx, increased
intraocular pressure in glaucoma patients.
Albuterol: Tachycardia, angina, tremors, especially with oral
preparations.
Montelukast: Neuropsychiatric effects including depression
and suicidal thoughts.
Beclomethasone: Oropharyngeal candidiasis, dysphonia,
adrenal suppression with long-term use.
Roflumilast: Diarrhea, weight loss, nausea, and potential
reproductive issues.
KEY MONITORING PARAMETERS
Peak Expiratory Flow (PEF): Regular monitoring to assess
asthma control and medication effectiveness.
Liver Function Tests (LFTs): Important for monitoring
patients on isoniazid and other hepatotoxic medications.
Symptom Intensity and Frequency: Monitoring for changes in
asthma symptoms, nighttime awakenings, and short-acting
beta agonist use.
Therapeutic Drug Monitoring: Essential for drugs with narrow
therapeutic ranges like theophylline.
